Further experiments in DLD-1 WT and DLD-1 ATRs/s cells revealed little impact of the ATR status on the sensitivity of CRC cells towards a combination of PARPi and chemotherapeutic drugs (Appendix A, Figure A7A,B). Here, ATR is linked to colorectal carcinoma.